Intranasal Fluticasone Propionate Inhibits Recovery of Chemokines and Other Cytokines in Nasal Secretions in Allergen-Induced Rhinitis
- 30 November 1996
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 77 (5) , 407-415
- https://doi.org/10.1016/s1081-1206(10)63340-6
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- lnterleukin-8 and Related Chemotactic Cytokines—CXC and CC ChemokinesPublished by Elsevier ,2008
- CC chemokines in allergic inflammationImmunology Today, 1994
- Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine.The Journal of Experimental Medicine, 1994
- Development of a new technique for recovery of cytokines from inflammatory sites in situJournal of Immunological Methods, 1992
- Macrophage inflammatory protein-1 alpha activates basophils and mast cells.The Journal of Experimental Medicine, 1992
- Effect of Topical Corticosteroids on the Recovery of Histamine Releasing Factors in Nasal Washings of Patients with Allergic Rhinitis: A Double-blind, Randomized, Placebo-controlled StudyAmerican Review of Respiratory Disease, 1992
- Topical glucocorticoids inhibit activation by allergen in the upper respiratory tractJournal of Allergy and Clinical Immunology, 1992
- Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils.Journal of Clinical Investigation, 1992
- Do Cytokines Play a Role in Leukocyte Recruitment and Activation in the Lungs?American Review of Respiratory Disease, 1991
- Inhibition of Mediator Release in Allergic Rhinitis by Pretreatment with Topical GlucocorticosteroidsNew England Journal of Medicine, 1987